CD69 and CD25 expressions within the CD3+CD8+ population of hu-PBMCs co-grafted with MDA-MB-231 cells in embryos treated either with NaCl or with pembrolizumab.
This promoter capture Hi-C data in tonsil-derived ILC3 cells accompanies the manuscript: "High-resolution promoter interaction analysis implicates genes involved in the activation of Type 3 Innate Lym
Proliferation of human CD4+ αβ T cells expressing a natural killer cell activating receptor (NKAR) has been shown to be enhanced, particularly in response to low doses of antigen, if the target cells
